This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1991 Mar 28;324(13):922-3.

doi: 10.1056/NEJM199103283241313.

Mortality experience in cholesterol-reduction trials

M F Muldoon, S B Manuck, K A Matthews

PMID: 2043196
DOI: 10.1056/NEJM199103283241313

Comment

Mortality experience in cholesterol-reduction trials

M F Muldoon et al. N Engl J Med. 1991.

. 1991 Mar 28;324(13):922-3.

doi: 10.1056/NEJM199103283241313.

Authors

M F Muldoon, S B Manuck, K A Matthews

PMID: 2043196
DOI: 10.1056/NEJM199103283241313

No abstract available

PubMed Disclaimer

Comment on

The value of lowering cholesterol after myocardial infarction.
Rossouw JE, Lewis B, Rifkind BM. Rossouw JE, et al. N Engl J Med. 1990 Oct 18;323(16):1112-9. doi: 10.1056/NEJM199010183231606. N Engl J Med. 1990. PMID: 2215579 Review. No abstract available.

Similar articles

Too little cholesterol reduction may be hazardous.
Vine DL. Vine DL. Kans Med. 1991 Feb;92(2):53-4. Kans Med. 1991. PMID: 2020156 No abstract available.
Cholesterol reduction therapy: a double-edged knife.
Ong HT. Ong HT. Med J Malaysia. 1993 Jun;48(2):107-12. Med J Malaysia. 1993. PMID: 8350783 Review.
[Current developments in prevention of coronary heart disease].
Windler E. Windler E. Z Arztl Fortbild (Jena). 1996 Feb;90(1):7-10. Z Arztl Fortbild (Jena). 1996. PMID: 8650967 German.
Prevention of cardiovascular morbidity and mortality in hypertension: benefits of blood pressure reduction and cholesterol lowering.
MacMahon S. MacMahon S. Postgrad Med J. 1989;65 Suppl 1:S55-7. Postgrad Med J. 1989. PMID: 2695910 Review. No abstract available.
Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
Marchioli R, Marfisi RM, Carinci F, Tognoni G. Marchioli R, et al. Arch Intern Med. 1996 Jun 10;156(11):1158-72. Arch Intern Med. 1996. PMID: 8639010 Review.

See all similar articles

Cited by

Lowering blood lipids to treat atherosclerosis: vascular tone, plaques, events, and mortality.
Rubba P, Pauciullo P, Mancini M. Rubba P, et al. Cardiovasc Drugs Ther. 1993 Nov;7(5):767-74. doi: 10.1007/BF00878928. Cardiovasc Drugs Ther. 1993. PMID: 8110618
The problem with cholesterol.
Dunnigan MG. Dunnigan MG. BMJ. 1993 May 22;306(6889):1355-6. doi: 10.1136/bmj.306.6889.1355. BMJ. 1993. PMID: 8518597 Free PMC article. No abstract available.
Calcium channel blockers. The jury is still out on whether they cause heart attacks and suicide.
Stanton AV. Stanton AV. BMJ. 1998 May 16;316(7143):1471-3. doi: 10.1136/bmj.316.7143.1471. BMJ. 1998. PMID: 9582126 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information